We are live on ! Find out more
AONC

American Oncology Network, Inc. Class A Common Stock

Delisted

AONC was delisted on the 7th of June, 2024.

65 hedge funds and large institutions have $245M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

7% more funds holding

Funds holding: 6165 (+4)

1% less capital invested

Capital invested by funds: $246M → $245M (-$1.73M)

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
16
Reduced
6
Closed
9
Calls
$472K
Puts
Net Calls
+$472K
Net Calls Change
+$4K
Name Holding Trade Value Shares
Change
Change in
Stake
PP
51
Paloma Partners
Connecticut
$668K
Nomura Holdings
52
Nomura Holdings
Japan
$588K +$586K +60,276 New
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
$499K
HF
54
HRT Financial
New York
$494K +$492K +50,656 New
PCM
55
Pinz Capital Management
New York
$492K
MTCM
56
Mint Tower Capital Management
Netherlands
$488K +$486K +50,000 New
Barclays
57
Barclays
United Kingdom
$433K +$431K +44,321 New
WAM
58
Wolverine Asset Management
Illinois
$361K +$360K +37,077 New
WRBC
59
W.R. Berkley Corp
Connecticut
$244K
SSA
60
Schonfeld Strategic Advisors
New York
$194K -$1.02K -105 -0.5%
AC
61
Antara Capital
New York
$188K
Geode Capital Management
62
Geode Capital Management
Massachusetts
$106K +$106K +10,892 New
Macquarie Group
63
Macquarie Group
Australia
$13.4K
UBS Group
64
UBS Group
Switzerland
$12K -$12.2K -1,251 -50%
TRCT
65
Tower Research Capital (TRC)
New York
$8K +$7.08K +729 +1,402%
UOC
66
UBS O'Connor
Illinois
-$3.42M -352,824 Closed
Blackstone Inc
67
Blackstone Inc
New York
-$2.44M -250,000 Closed
KLM
68
Kennedy Lewis Management
New York
-$1.95M -200,000 Closed
DCP
69
Diameter Capital Partners
New York
-$1.46M -150,000 Closed
MP
70
Mangrove Partners
Connecticut
-$975K -100,000 Closed
VAS
71
VR Advisory Services
Cayman Islands
-$857K -88,260 Closed
OMC
72
Old Mission Capital
Illinois
-$327K -33,715 Closed
Qube Research & Technologies (QRT)
73
Qube Research & Technologies (QRT)
United Kingdom
-$252K -25,974 Closed

AONC Hedge Fund Activity: Q1 2022 in Review

65 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2022, worth a combined $245M — down 0.7% from $246M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AONC positions and 9 closed out — a net gain of 4 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Alberta Investment Management Corp (AIMCo), opening a new position worth an estimated $3.4M. The largest seller was UBS O'Connor, exiting entirely with an estimated $3.42M sold.

  • 65 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2022, up from 61 in Q4 2021.
  • Funds reported $245M of American Oncology Network, Inc. Class A Common Stock stock for Q1 2022, down 0.7% quarter-over-quarter.
  • 13 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2022 and 9 closed out, a net change of +4 holders.
  • The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2022 was Alberta Investment Management Corp (AIMCo), an estimated $3.4M added.
  • The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $3.42M sold.

Based on aggregated 13F filings for Q1 2022.